Questcor Reports Second Quarter Results - MarketWatch

WELT ONLINE

Questcor Reports Second Quarter Results MarketWatch - 4 hours ago The Company's most important growth initiative is the planned 2008 resubmission to the FDA of the sNDA in support of a new indication for IS. ... Lilly Reports Solid Second-Quarter Results PR Newswire (press release) all 448 news articles

More Articles from Same Category: FDA

Teva receives FDA approval for generic Risperdal - BusinessWeek

Teva receives FDA approval for generic Risperdal
BusinessWeek - 14 hours ago
Teva Pharmaceutical Industries Ltd. said Monday it received Food and Drug Administration approval for a generic version of Johnson & Johnson's blockbuster ...
FDA Approves First Generic Risperidone to Treat Psychiatric Conditions FDA.gov
Teva Receives FDA Approval for Generic Risperdal

ALDA Receives FDA Permission to Sell Products in the US - MarketWatch (press release)

ALDA Receives FDA Permission to Sell Products in the US
MarketWatch (press release)
Dr. Terrance Owen, President & CEO, states, "Receiving the NDC number from the FDA provides ALDA with the consent that is needed to introduce our products ...
FDA gives Alda Pharmaceuticals drug code to

FDA warns against using Clarcon skin products - The Associated Press

FDA warns against using Clarcon skin products
The Associated Press
Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, issued a voluntary recall of some skin sanitizers and skin protectants marketed under several different brand names, the FDA said in a statement. Consumers should not use any Clarcon products

FDA Approves Amgen Inc.'s Nplate Drug For The Fight Against ITP - eFluxMedia

Chatter Shmatter
FDA Approves Amgen Inc.'s Nplate Drug For The Fight Against ITP
eFluxMedia - 14 hours ago
By Alex Garrel On Friday, the Food and Drug Administration (FDA) gave its approval for Amgen Inc.'s drug called Nplate, therefore it will be made available ...
FDA approves Amgen's blood platelet booster Reuters
FDA Approves

FDA Approves a Novel Novartis Drug - Wall Street Journal

FDA Approves a Novel Novartis Drug
Wall Street Journal
By JEANNE WHALEN The Food and Drug Administration Thursday approved the sale of Novartis AG's Ilaris, the first drug the company has developed as part of its new push to focus on the genetic triggers that cause disease. Ten years

Ranbaxy Launches Generic Valtrex in US - Wall Street Journal

Rediff
Ranbaxy Launches Generic Valtrex in US
Wall Street Journal
"Ranbaxy Pharmaceuticals has introduced valacyclovir hydrochloride, 500 milligram and 1 gram tablets, having previously been granted US FDA approval for ...
Ranbaxy launches generic version of Valtrex in USLivemint
Ranbaxy takes on GSK's Valtrex in USTimes of

Related Articles: Questcor Reports Second Quarter Results - MarketWatch

Hypertension Diagnostics Announces First Quarter Fiscal Year 2010 Results - PR-USA.net (press release)

Alkermes drug wins second FDA approval - Bizjournals.com

PsychCentral.com
Alkermes drug wins second FDA approval
Bizjournals.com, NC
Drug maker Alkermes Inc. said one of its products, a therapy for schizophrenia, has received an additional approval from the US Food and Drug Administration to be used for the treatment of bipolar disorder. RISPERDAL CONSTA , which is sold by Johnson ...
J&J

Statement by Dr. Anthony Fauci, Director, National Institute of Allergy and Infections Diseases, NIH, Regarding Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults
WASHINGTON--(BUSINESS WIRE)--Sep 11, 2009 - We are encouraged by reports that are now emerging from various clinical trials of 2009 H1N1 influenza vaccines, conducted by various vaccine manufacturers. We expect additional companies to announce... (Source: Drugs.com - Clinical Trials)

Orexo AB reports year-end 2009 financial results
Sales of Abstral continue to show robust growth, with royalty revenues rising sharply during the fourth quarter – up threefold from the preceding quarter. Our partner, ProStrakan, launched during 2009 Abstral in UK, Germany, France, Spain and Greece, and product launches in additional markets are imminent. Sales growth

SARS Corp. Subsidiary FasTech Services Awarded New Contract ... - MarketWatch (press release)

SARS Corp. Subsidiary FasTech Services Awarded New Contract ...
MarketWatch (press release)
FastTech merged with SARS to take advantage of SARS' experience with remote monitoring technology, and we're pleased to realize the initial benefits of this ...

and more »

Acorda Therapeutics reports AMPYRA gross sales of $3.4 million for first-quarter 2010
Acorda Therapeutics, Inc. today announced its financial results for the first quarter of 2010.

Latest Searches: Allopan option com joomlapicasa2 option com joomlapicasa2, I option com joomlapicasa2 option com joomlapicasa2, t722t, Y option com joomlapicasa2 option com joomlapicasa2, zomsisueoeriyjskwkdejsrfeyare land ru html body, lov a option com joomlapicasa2, ringtones downloads free, us errors errors, hypomania, t575t, t131t option com joomlapicasa2 option com joomlapicasa2, lovaxa index php option com joomlapicasa2, t631t, fight, t77t, t127t. Top Searches...

Common typos for 'Questcor Reports Second Quarter Results MarketWatch' : qu-estcor reports second -quarter results marketwatch, questcor rep orts second quarter results marketwatchh, questcor reports second quarter results maretwatch, questcor reports second quarter rseults marketwatch, questcor reports second quarter result marketwatch, questcor reports second quarter res ults marketwatch, quuestcor reports second quarter results marketwatch, questcor reports second q7arter results marketwatch, questcor reports second quart er results marketwatch, questcor reports secondd quarter results marketwatch, questcor reports sscond quarter results marketwatch, questcor reports second quarter results m-arketwatch, questcor reports second quarter r-seults marketwatch, questcor reports second quarter reslts marketwatch, questcor reports second quarter results markewatch, qu-estcor reports seco-nd quarter results marketwatch, questcor reports second quarter results marketwach, questcor reporfs second- quarter results marketwatch, questcor reports- second quarter results marketwatch, questcorr rwports second quarter results marketwatch, questcor reports second quarter resultsmarketwatch, questcor reports second quarter rsults marketwatch, qetcor reports second quarter results marketwatch, questcor reports second quarter rsults marketwathc, questcor reports second quarter results marketwagch, questcor reports second quartre results marketwatch, questcor reports second qurter results marketwach, quetscor reports second quarter results marketwatch, questcor reports second quarter results marektwatch, questcor reports second quqrte5 results marketwatch, questco-r reports second quarter results marketwatch, questcor report-s second qua rter results marketwatch.
More 'Questcor Reports Second Quarter Results MarketWatch' Typos...